Among 34 individuals with PMMTs, pathogenic variants in the BRCA1 gene occurred in two cases (6%); the other tumors were colorectal and ovarian cancer in one case, and lung cancer in another. This evidence concerns the gene BRCA1 and ovarian carcinoma.